Found 82 matching trials
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer
NAThe purpose of this clinical trial is to determine whether using chemothera...
Location
Miami Cancer Institute at Baptist Health, Inc.
Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
PHASE1The study is an open-label pilot study in newly diagnosed glioblastoma pati...
Location
University of California San Francisco
Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)
PHASE1The study is a prospective, single arm, non-randomized, open label pilot tr...
Location
Multiple Locations
WBSI Guided Personalized Delivery of TTFields
NAThis research study is for Glioblastoma (GBM) patients who will be beginnin...
Location
Abramson Cancer Center
TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
N/AThe purpose of this post-authorisation medical device study is to obtain re...
Location
Lungenklinik Gauting
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM
NATo test the effectiveness and safety of Optune® given concomitantly with ra...
Location
Grandview Cancer Center
TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study
N/AThis non-interventional study aims to investigate change over time in cogni...
Location
Universitätsklinikum Aachen
Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation
NAThe purpose of the study is to assess timing of TTFields use as well as saf...
Location
University Hospital of Heidelberg, Radiation Oncology
Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)
PHASE2The study is a prospective, single arm, non-randomized, open label phase II...
Location
Antwerp University Hospital, Thoracic Oncology
Lenvatinib, Pembrolizumab, and Tumor Treating Fields (TTFields) for Second-line Treatment of Glioblastoma
PHASE1This will be a prospective, open label, single center, phase I lead-in stud...
Location
Multiple Locations